Botanical names Cinnamomum cecidodaphne
Source Fruits
Family Lauraceae
Origin Nepal
Processing Method Steam Distillation
Description / Color / Consistency A thin, yellow to golden liquid.
Aromatic Summary / Note / Strength of Aroma A middle note with a medium aroma, Sugandh Kokila has a very distinctive scent that is spicy and camphoraceous.
Blends With Sugandh Kokila Essential Oil does not typically blended with other oils.
Product Abstract
Sugandha Kokila Oil. The evergreen, Cinnamomum glaucescens, part of the Lauraceae family, is native to Nepal and grows wild in the districts of Dang, Rolpa and Sallyan in the Rapit Zone. Sugandha Kokila increases circulation, reduces pain and inflammation in the muscles and joints, relieves arthritis (great blended with juniper). Also helps to control infections. Also known in Nepal as Himalayan Cinnamon Fruit oil and said to be "A Gift to Perfumers from the Himalayan Kingdom of Nepal."
History
Sugandha Kokila scientifically known as Cinnamomum glaucescens is a member of the Lauraceae family. The ancient Ayurvedic texts recommend the use of this oil as a natural tonic for the digestive system and the central nervous system.
Harvesting/Extraction Information
Citizens of Nepal have been collecting wild herbs and berries from the natural environment for centuries, where both women and men traditionally carry out the harvesting practice. Today, the harvesting of MAPs is regulated by The Department of Forests, under the Ministry of Forests and Soil Conservation. While wild aromatic and medicinal plants are the property of the government, any citizen is free to harvest them after applying to the department of forests and paying government royalty fees. Sugandha kokila oil is a product of steam distillation from the dried berries of Cinnamomum glaucescens. This process enables the sugandha kokila oil to be distilled at a temperature significantly lower than its boiling point.
Common usage
Caution
Dilute before use; for external use only. May cause skin irritation in some individuals; a skin test is recommended prior to use. Contact with eyes should be avoided.
Key constituents
(E)-Methyl cinnamate 13.7%
1,8-Cineole 13.1%
b-Caryophyllene 7.4%
a-Terpineol 6.6%
a-Copaene 4.7%
Terpinen-4-ol 4.0%
p-Cymene 3.6%
2-Undecanone 3.6%
d-Cadinene 2.9%
Linalool 2.8%
Lauric acid 2.7%
Myristicin 2.5%
a-Santalene 2.1%
2-Nonanone 1.9%
b-Pinene 1.9%
Camphor 1.5%
a-Phellandrene 1.5%
b-Phellandrene 1.4%
a-Caryophyllene 1.3%
Decanoic acid 1.3%
a-Pinene 1.2%
b-Bisabolene 1.1%
b-Selinene 1.0%
Methyleugenol 0.6%
Safety summary
Hazards Potentially carcinogenic, based on methyleugenol content.
Contraindications None known.
Maximum dermal use level
EU 0.03%
IFRA 0.06%
Tisserand & Young 3.3%
Our safety advice
We recommend a dermal maximum of 3.3%, based on 0.6%
methyleugenol content with a dermal limit of 0.02%
Regulatory guidelines
IFRA recommends a maximum concentration of 0.0004% methyleugenol in leave-on products such as body lotions. The equivalent SCCNFP maximum is 0.0002%.
Organ-specific effects
Adverse skin reactions No information found.
Systemic effects
Acute toxicity No information found.
Carcinogenic/anticarcinogenic potential No information found. Methyleugenol is a rodent carcinogen when exposure is sufficiently high; anticarcinogenic activity has been reported for myristicin, a-caryophyllene and b-caryophyllene
Comments
Produced in Nepal.
.png)
